Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Letter
- PMID: 38298141
- DOI: 10.1158/1078-0432.CCR-23-3444
Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Letter
Comment in
-
Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response.Clin Cancer Res. 2024 Feb 1;30(3):639. doi: 10.1158/1078-0432.CCR-23-3603. Clin Cancer Res. 2024. PMID: 38298142 No abstract available.
Comment on
-
Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma.Clin Cancer Res. 2024 Jan 5;30(1):106-115. doi: 10.1158/1078-0432.CCR-23-1180. Clin Cancer Res. 2024. PMID: 37910594 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
